Prof. Dr. Aysun Soysal

Significance of Phrenic Nerve Conduction Study in the Electrodiagnosis of Guillain Barré Syndrome

Journal of the Peripheral Nervous System, 2026

DOI 10.1111/jns.70131 PMID 42227702 Açık erişimli tam metinKaynak: ORCID

CD8+CD20+ Cytotoxic T Lymphocytes Exhibit Augmented Degranulation and Pro-inflammatory Potential in Multiple Sclerosis

Biorxiv, 2026

DOI 10.64898/2026.01.29.702512 Açık erişimli tam metinKaynak: ORCID

Causal effects of multiple sclerosis therapies in left-truncated registry data

Multiple Sclerosis Journal, 2026

DOI 10.1177/13524585261459943 PMID 42479470 Açık erişimli tam metinKaynak: ORCID

Differential Associations Between Left Atrial Volume Parameters and Ischemic Stroke Subtypes

Haseki Tip Bulteni, 2026

DOI 10.4274/haseki.galenos.2026.70299 Açık erişimli tam metinKaynak: ORCID

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry

Journal of Neurology, 2026

DOI 10.1007/s00415-026-13632-4 PMID 41634506 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Evaluation of Seropositivity Developed Against Specific Antigens of Helicobacter pylori in Neurodegenerative Diseases

Noropsikiyatri Arsivi, 2026

DOI 10.29399/npa.29038 PMID 41613025 Açık erişimli tam metinKaynak: ORCID

Hyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke

Frontiers in Neurology, 2026

DOI 10.3389/fneur.2026.1723099 PMID 41940303 Açık erişimli tam metinKaynak: ORCID

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder

Neurology, 2026

DOI 10.1212/wnl.0000000000214707 PMID 41785437 Kaynak: ORCID

Predicting disease progression in multiple sclerosis with clinically accessible information and technology

Journal of Neurology, 2026

DOI 10.1007/s00415-026-13802-4 PMID 42002655 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study

CNS Drugs, 2026

DOI 10.1007/s40263-026-01287-8 PMID 41935174 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Reduced vagal reserve in benign paroxysmal positional vertigo: preliminary results of a case-control HRV study

European Archives of Oto Rhino Laryngology, 2026

DOI 10.1007/s00405-026-10479-3 PMID 42507201 Kaynak: ORCID

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

Medrxiv, 2026

DOI 10.64898/2026.03.09.26347918 Açık erişimli tam metinKaynak: ORCID

Sensory neuronopathy: evaluation of clinical and electrophysiological features, etiology, and treatment responses

Neuroscience Applied, 2026

DOI 10.1016/j.nsa.2025.105726 Açık erişimli tam metinKaynak: OpenAlex

Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing

Document Server@UHasselt (UHasselt), 2026

Açık erişimli tam metinKaynak: OpenAlex

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

Brain, 2026

DOI 10.1093/brain/awag252 PMID 42496160 Açık erişimli tam metinKaynak: OpenAlex

How patients with neuromyelitis optica spectrum disease accumulate disability

Multiple Sclerosis Journal, 2026

DOI 10.1177/13524585261489039 PMID 42847346 Açık erişimli tam metinKaynak: OpenAlex

Disease-modifying therapies in managing disability worsening in adult relapsing multiple sclerosis: a population-based longitudinal study using the MSBase registry

BMC Medicine, 2026

DOI 10.1186/s12916-026-05365-y Açık erişimli tam metinKaynak: OpenAlex

Antibodies against SARS-CoV-2 in cerebrospinal fluid: Clinical features and laboratory findings of hospitalized patients with neurologic symptoms in the pandemic era,SARS-CoV-2 elleni antitestek az agygerincvelői folyadékban: neurológiai tünetekkel kórházba került betegek klinikai jellemzői és laboratóriumi leletei a világjárvány idején

Ideggyogyaszati Szemle, 2025

DOI 10.18071/isz.77.0136 PMID 40163003 Kaynak: ORCID

CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders

Journal of Immunology, 2025

DOI 10.1093/jimmun/vkaf205 PMID 40849886 Açık erişimli tam metinKaynak: ORCID

CD20+ natural killer cells are polyfunctional, memory-like cells that are enriched in inflammatory disorders

Biorxiv, 2025

DOI 10.1101/2025.01.09.632131 Açık erişimli tam metinKaynak: ORCID

Clinical Characteristics and Prognostic Clinical Factors of Anti-Gamma-Aminobutyric Acid-B Receptor (Gabab-R) Encephalitis in Turkiye: A Multicenter Study

Ssrn, 2025

DOI 10.2139/ssrn.5063432 Kaynak: ORCID

Clinical characteristics and prognostic clinical factors of anti-gamma-aminobutyric acid-B receptor (GABAB-R) encephalitis in Türkiye: a multicenter study

Neurological Research, 2025

DOI 10.1080/01616412.2025.2495932 PMID 40314255 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Evaluating the Impact of Heroin Abuse on Cerebral Bioelectrical Activity in Adolescents: A Quantitative Electroencephalography Study

Neurological Sciences and Neurophysiology, 2025

DOI 10.4103/nsn.nsn_41_25 Açık erişimli tam metinKaynak: ORCID

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Neurotherapeutics, 2025

DOI 10.1016/j.neurot.2025.e00552 PMID 39965993 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Npj Digital Medicine, 2025

DOI 10.1038/s41746-025-01788-8 PMID 40707601 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study

Journal of Neurology Neurosurgery and Psychiatry, 2025

DOI 10.1136/jnnp-2024-334090 PMID 39231582 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry

Therapeutic Advances in Neurological Disorders, 2025

DOI 10.1177/17562864251399595 PMID 41466847 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis

JAMA Neurology, 2025

DOI 10.1001/jamaneurol.2025.0495 PMID 40227706 44 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Vaccination strategies in multiple sclerosis patients with Delphi methodology: A Turkish consensus

Neurology Asia, 2025

DOI 10.54029/2025eme Açık erişimli tam metinKaynak: ORCID

Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Multiple Sclerosis Journal, 2025

DOI 10.1177/13524585251349125 PMID 40621862 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability

JAMA Network Open, 2025

DOI 10.1001/jamanetworkopen.2025.31581 PMID 40952740 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

ECTRIMS 2025 Paper Poster Session 1 and 2

Multiple Sclerosis Journal, 2025

DOI 10.1177/13524585251358344 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

AB-290. Effectiveness of intermittent theta burst stimulation as an adjunct to constraint-induced movement therapy in patients with stroke to enhance upper extremity recovery: A randomized controlled study

Clinical Neurophysiology, 2025

DOI 10.1016/j.clinph.2025.02.098 Kaynak: OpenAlex

Electrodiagnostic methods to verify Guillain‐Barré syndrome subtypes in Istanbul: A prospective multicenter study

Journal of the Peripheral Nervous System, 2024

DOI 10.1111/jns.12612 PMID 38291679 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis

Biomedicines, 2024

DOI 10.3390/biomedicines13010040 PMID 39857624 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Development, Validity and Reliability of the “Multiple Sclerosis Stigma Scale”

Multiple Sclerosis and Related Disorders, 2024

DOI 10.1016/j.msard.2024.105945 PMID 39461168 Kaynak: ORCID

The relationship between optic nerve sheath diameter and demographic and clinical findings in patients diagnosed with clinically isolated syndrome

Turkish Journal of Clinics and Laboratory, 2024

DOI 10.18663/tjcl.1549222 Açık erişimli tam metinKaynak: ORCID

Arm Swing Movements during Walking as an Early Predictor of Multiple Sclerosis Progression

Applied Sciences, 2024

DOI 10.3390/app14156605 Açık erişimli tam metinKaynak: ORCID

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Journal of Neurology, 2024

DOI 10.1007/s00415-024-12518-7 PMID 38935148 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

A multicenter multinational study to evaluate different aspects of the relationship between MS and pregnancy

Multiple Sclerosis and Related Disorders, 2024

DOI 10.1016/j.msard.2024.105811 PMID 39305566 Kaynak: ORCID

Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein

Balkan Medical Journal, 2024

DOI 10.4274/balkanmedj.galenos.2024.2024-1-97 PMID 38828767 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

Journal of Medical Economics, 2024

DOI 10.1080/13696998.2023.2293379 PMID 38085684 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Disease Activity in Pregnant and Postpartum Women with Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies

Neurology Neuroimmunology and Neuroinflammation, 2024

DOI 10.1212/nxi.0000000000200328 PMID 39442037 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

Clinical and Experimental Immunology, 2024

DOI 10.1093/cei/uxad103 PMID 37638717 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Effectiveness of Intermittent Theta Burst Stimulation to Enhance Upper Extremity Recovery After Stroke: A Pilot Study

Archives of Physical Medicine and Rehabilitation, 2024

DOI 10.1016/j.apmr.2024.05.025 PMID 38862033 1 atıf (Europe PMC) Kaynak: ORCID

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal, 2024

DOI 10.1177/13524585241267211 PMID 39087208 19 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Efficacy of novel haemogram parameters in the evaluation of inflammation in acute ischemic stroke

Neurology Asia, 2024

DOI 10.54029/2024yxm 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

Hereditary polyneuropathy with conduction block associated with SORD mutation in three siblings

Acta Neurologica Belgica, 2024

DOI 10.1007/s13760-023-02320-z PMID 37418112 2 atıf (Europe PMC) Kaynak: ORCID

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study

Plos Digital Health, 2024

DOI 10.1371/journal.pdig.0000533 PMID 39052668 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Priming constraint-induced movement therapy with intermittent theta burst stimulation to enhance upper extremity recovery in patients with stroke: protocol for a randomized controlled study

Acta Neurologica Belgica, 2024

DOI 10.1007/s13760-024-02472-6 PMID 38329642 1 atıf (Europe PMC) Kaynak: ORCID